Viewing Study NCT06754267


Ignite Creation Date: 2025-12-25 @ 12:53 AM
Ignite Modification Date: 2026-01-02 @ 5:37 AM
Study NCT ID: NCT06754267
Status: RECRUITING
Last Update Posted: 2024-12-31
First Post: 2024-12-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Venetoclax Combined With Olverembatinib and Predinisone in Treating Ph+ B-ALL
Sponsor: First Affiliated Hospital of Zhejiang University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module